Boston, MA -- (SBWire) -- 06/10/2013 --C. R. Bard, Inc. (Bard) is a multinational medical device company. It carries out the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. It offers life-enhancing medical technologies in the areas of Vascular, Urology, Oncology and Surgical Specialty products. The company offers its wide range of products to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. The company conducts its operations across Americas, Europe, Asia pacific, the Middle East and Africa. It has international manufacturing facilities in Puerto Rico, Germany, France, Belgium, Mexico and Malaysia. Bard is headquartered in New Jersey, the US.
View Full Report Details and Table of Contents
The company seeks to build its position in the marketplace through internal development, partnerships, strategic alliances and acquisition of complementary businesses, technologies and products. As part of its strategy, Bard recently acquired Lutonix, Inc., Medivance, Inc., and ClearStream Technologies Group plc.
This report is a source for data, analysis and actionable intelligence on the C. R. Bard, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Medical Devices research reports at Fast Market Research
You may also be interested in these related reports:
- C. R. Bard, Inc. (BCR) - Financial and Strategic SWOT Analysis Review
- C. R. Bard, Inc. Market Share Analysis
- Qiagen N.V. (QIA) - Product Pipeline Analysis, 2013 Update
- Alere Inc. (ALR) - Product Pipeline Analysis, 2013 Update
- Hologic, Inc. (HOLX) - Product Pipeline Analysis, 2013 Update
- Analyticon Biotechnologies AG - Product Pipeline Analysis, 2013 Update
- Varian Medical Systems, Inc. (VAR) - Product Pipeline Analysis, 2013 Update
- Aethlon Medical, Inc. (AEMD) - Product Pipeline Analysis, 2013 Update
- W. L. Gore & Associates, Inc. - Product Pipeline Analysis, 2013 Update
- MolecularMD, Corp. - Product Pipeline Analysis, 2013 Update
"C. R. Bard, Inc. (BCR) - Product Pipeline Analysis, 2013 Update" Published
New Medical Devices research report from GlobalData is now available from Fast Market Research